![Frank Benesch-Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Frank Benesch-Lee was the founder and had worked as a Chief Engineer at Myomics, Inc. which was founded in 2003.
He obtained his undergraduate degree from Technische Hochschule Rosenheim in 2001.
Former positions of Frank Benesch-Lee
Companies | Position | End |
---|---|---|
Myomics, Inc.
![]() Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Founder | - |
Training of Frank Benesch-Lee
Technische Hochschule Rosenheim | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Myomics, Inc.
![]() Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Health Technology |
- Stock Market
- Insiders
- Frank Benesch-Lee